Komori
Medikit (7749) · RiskRestated

Risk of Supply Disruptions for Raw Materials and Components

First written in FY2020. 10 of 12 entries say "Restated". Latest entry: FY2025.

12entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2020 – FY2021-Q3RestatedFY2022-Q1 – FY20252020: 120202021: 420212022: 420222023: 120232024: 120242025: 12025
Same theme, other companies
Disruptions in the Procurement of Raw Materials and Parts and Supplier Business Continuity RiskA theme 120 companies write about · 120 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2021: 44 of 75 companies on the "Worse" side.

30 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 120 companies compared. The sentences above are computed from all 120.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「Our group is working to purchase from and secure supplies through multiple suppliers, develop new supply routes and reduce procurement costs.」

    The company continues to address dependence on external suppliers and production and shipment delays caused by supply disruptions through multiple suppliers and new supply routes.
  2. FY2024-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company has reconfirmed the risk of disruption to the supply of raw materials and parts through a comprehensive statement that there have been no new occurrences or material changes.
  3. FY2024-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company has reconfirmed the risk of disruption to the supply of raw materials and parts through a comprehensive statement that there have been no material changes.
  4. FY2023-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company has reconfirmed the risk of disruption to the supply of raw materials and parts through a comprehensive statement that there have been no material changes.
  5. FY2023-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company has reconfirmed the risk of disruption to the supply of raw materials and parts through a comprehensive statement that there have been no material changes.
  6. FY2022RestatedAnnual report

    「Our group is working to purchase from and secure supplies through multiple suppliers, develop new supply routes and reduce procurement costs.」

    The company continues to address the risks of dependence on external suppliers and production and shipment delays caused by supply disruptions through multiple suppliers and new supply routes.
  7. FY2022-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company has reconfirmed the risk of disruption to the supply of raw materials and parts through a comprehensive statement that there have been no material changes.
  8. FY2022-Q2RestatedAnnual report

    「During the cumulative second quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company has reconfirmed the risk of disruption to the supply of raw materials and parts through a comprehensive statement that there have been no material changes.
  9. FY2022-Q1RestatedAnnual report

    「During the cumulative first quarter under review, there were no new business or other risks, nor any material changes to the business or other risks described in the annual securities report for the previous fiscal year.」

    The company has reconfirmed the risk of disruption to the supply of raw materials and parts through a comprehensive statement that there have been no material changes.
  10. FY2021MitigatedAnnual report

    「Our group is working to purchase from and secure supplies through multiple suppliers, develop new supply routes and reduce procurement costs.」

    In response to the risk of disruption to the supply of raw materials and parts, the company explicitly describes diversification measures involving multiple suppliers and the development of new supply routes.
  11. FY2021-Q3RestatedAnnual report

    「During the cumulative third quarter of the current consolidated fiscal year, there were no new business or other risks, nor any material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    The company has reconfirmed the risk of disruption to the supply of raw materials and parts through a comprehensive statement that there have been no material changes.
  12. FY2020First statedAnnual report

    「Our group’s production activities depend on supplies of raw materials and parts from suppliers outside the group. If supply is disrupted for reasons attributable to a supplier, production and shipment of products may be delayed, potentially affecting our group’s business performance.」

    The company has for the first time identified dependence on external suppliers for raw materials and parts and production and shipment delays caused by supply disruptions as separate risks.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Medikit's next results are scheduled for 2026-11-12. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Risk of Supply Disruptions for Raw Materials and Components | MEDIKIT CO.,LTD. (7749) | Komori